Introduction
============

With the rapid developments in nanoscience and nanotechnology in recent years, various types of nanomaterials have been widely applied in areas of medicine, biology and food manufacturing because of the unique physicochemical properties and innovative function of these materials [@B1]-[@B3]. Many nanomaterials naturally exist within environmental pollution and can also be either produced or engineered intentionally [@B4]. Although the benefits of nanotechnology have a large scope, increasing public and occupational exposure to nanomaterials have caused public concern regarding their adverse effects. Previous studies have shown that nanoparticles cause pulmonary injury, hepatotoxicity, renal toxicity, immunotoxicity, neurotoxicity and testis damage in animal models [@B5]-[@B11]. However, the female reproductive system is considerably more sensitive than other systems. Many studies regarding the toxicity of nanoparticles in the female reproductive system have been conducted [@B12],[@B13]. TiO~2~ nanoparticles were found to cause ovarian dysfunction, and an intravenous injection of SiO~2~ and TiO~2~ into pregnant mice was observed to decrease the uterine weight and increase fetal reabsorption [@B14]. In addition, other nanoparticles, such as gold and carbon nanoparticles, can also penetrate the placental barrier in mice [@B15],[@B16]. Some reports also demonstrated that nanoparticles can cross the mouse placental barrier and induce apoptosis in trophoblast cells [@B17],[@B18]. A recent study founded that prenatal exposure to Cu-NPs caused a profound pulmonary inflammation in dams and strong immunomodulatory effects in offspring [@B19]. However, there are no studies describing the toxicity of Cu-NPs in the female reproductive system.

Copper is an essential trace element that helps maintain homeostatic function in living organisms [@B20]. Both copper deficiency and overload can lead to several diseases in humans [@B21]. *In vivo* and *in vitro* experiments have reported that copper is toxic to the reproductive system and a developing embryo [@B22],[@B23]. Previous research showed that water-soluble copper salts exhibited the highest reproductive toxicity in worms followed by copper nanoparticles (Cu-NPs) and copper exposure in the soil^23^. The toxicity due Cu-NPs exposure was probably caused by both the nanoparticles and Cu^2+^ released from the Cu-NPs [@B24],[@B25].

Cu-NPs are now industrially produced and commercially available. They are extensively used as wood preservatives as well as an additive in lubricants, polymers/plastics, and metallic coating inks [@B26],[@B27]. These nanoparticles are likely to be released into the environment and enter the human body via effluent, consumer products, or improper disposal [@B28]. Earlier studies have shown that Cu-NPs can lead to injuries of the kidney, liver and spleen in mice as well as alter serum markers of the liver and kidney [@B25],[@B29]. Cu-NPs have also been shown to cause embryonic damage and change the physiology of zebrafish [@B10]. In addition, Cu-NPs decreased the reproductive capacity of red worms [@B24]. However, few studies have reported the toxicity of Cu-NPs in the reproductive systems of mammal.

In the present work, we prepared Cu-NPs (approximate 100 nm) and examined their cytotoxicity in human extravillous trophoblast cells *in vitro*. Furthermore, we explored the systemic reproductive toxicity of Cu-NPs *in vivo* in a mouse model by examining the sex hormones and evaluating the function and structure of the ovary, placenta and other associated reproductive organs. We discovered that Cu-NPs exerted obvious reproductive toxicity on the mice by disrupting the balance of sex hormones as well as cytotoxicity on human extravillous trophoblast cells via ERK signaling and the mitochondria apoptosis pathway.

Materials and Methods
=====================

Synthesis and characterization of Cu-NPs
----------------------------------------

Cu-NPs (approximate 100 nm) were purchased from a nanomaterial company (Suzhou Tanfeng Graphene Tech. Inc. China) and had a mean nominal diameter of 100 nm and a purity of 99.5%. All stock solutions were stored at 4℃. Stock solutions of the nanoparticles (200μg/mL) were prepared in D-5-W (5% dextrose in water) and diluted to the required concentrations using the cell culture medium. The nanoparticles were applied after 5 min of sonication and 1 min of vortexing. To explore the characteristics of the Cu-NPs synthesized in this experiment, transmission electron microscopy (TEM), X-ray diffraction (XRD), and fourier transform infrared spectrometer (FIRT) were all performed, and the diameter of the nanoparticles was estimated. X-ray photoelectron spectra (XPS) was performed using a Thermo Fisher ESCALAB250Xi instrument (Thermo Fisher, Waltham, MA, USA) with Al Kα radiation as the exciting source.

Cell culture
------------

Cells were acquired from the Cell Bank of Typical Culture Collection (Chinese Academy of Sciences, Shanghai, China) and stored at our laboratory. The immortalized human first-trimester extravillous trophoblast cell line (HTR-8/SVneo) used in this study was grown in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% (vol/vol) heat-inactivated fetal calf serum. The cells were maintained at 37℃ in a humidified environment containing 5% CO~2~.

Cell viability survey
---------------------

To evaluate the cytotoxicity of Cu-NPs, HTR-8/SVneo cells in the logarithmic growth phase were seeded into a 96-well culture plate at 2000 cells per well and incubated at 37℃ in a humidified environment containing CO~2~ for 24 h until the cells adhered to the plate. Then, the cells were treated with various concentrations of Cu-NPs (0, 5, 10, 20, or 40 µg/mL) for both 48 h and 72 h, after which cell viability was assessed using a CCK-8 detection kit (Sigma, Milwaukee, WI, USA) according to the manufacturer\'s instructions. Briefly, after treatment with the different concentrations of Cu-NPs, 20 µl of CCK-8 solution was added to each well, and the plate was incubated at 37℃ for 2 h. Then, the inhibition of HTR-8/SVneo cell proliferation was determined based on the absorbance measurements at a wavelength of 450 nm using a microplate reader (Bio-Rad).

Apoptosis survey
----------------

HTR-8/SVneo cells were seeded into six-well plates (1×10^6^ per well). After the cells were cultured for 24 h, the medium was replaced with fresh complete medium, and the cells were treated with 0, 5, 10, 20, or 40 µg/mL Cu-NPs for either 48 h or 72 h. To measure the extent of apoptosis, the cells were then harvested and stained with propidium iodide (PI) and annexin V-FITC using a commercially available kit (BD Pharmingen, San Diego, CA, USA) according to the manufacturer\'s instructions and were analyzed by flow cytometry on a MACSQuant Analyzer (Miltenyi Biotec). The percentage of apoptotic cells was calculated using FlowJo 7.6.

Determination of cell cycle
---------------------------

Cell cycle analysis was conducted by PI staining followed by flow cytometry. Briefly, HTR-8/SVneo cells were treated with different concentrations of nanoparticles (5, 10, 20, and 40μg/mL) for 48 h or72 h. Treated and untreated control cells were harvested, washed twice with phosphate-buffered saline (PBS), and fixed in ice-cold ethanol (70%) for 4 h at 4℃. The fixed cells were washed, pelleted, resuspended in PBS, stained with a solution containing PI and RNase (40μg/mL and 100μg/mL, respectively) and incubated at 37℃ for 30 min until analysis. Flow cytometry was performed using an Epics Altra flow cytometer (Beckman Coulter) at an excitation wavelength of 488 nm and an emission wavelength of 610 nm. The data collected for 2×10^4^ cells per conditionwereanalyzed using WinMDI 2.8 software.

Measurement of the mitochondrial membrane potential
---------------------------------------------------

HTR-8/SVneo cells in six-well plates were treated with Cu-NPs (10, 20, or 40 mg/ml) for 12 h. The mitochondrial membrane potential (MMP) was monitored using the JC-1 mitochondrial membrane potential detection kit (Biotium, Hayward, CA, USA). In healthy cells, JC-1 (a fluorescent cationic dye) enters the negatively charged mitochondria, where the dye aggregates and fluoresces red. In cells in which the MMP has collapsed, JC-1 exists as monomers throughout the cell, which fluoresce green. Consequently, mitochondrial depolarization is indicated by a decrease in the ratio of the red:green fluorescence intensities. Data acquisition was performed using a MACSQuant Analyzer BD-FACS Canto II (Miltenyi Biotec, Becton-Dickinson, San Jose, CA, USA), and the data were analyzed using FlowJo 7.6 software (Tree Star, Inc., Ashland, MA, USA).

Western blotting analysis
-------------------------

Briefly, HTR-8/SVneo cells were treated with Cu-NPs at a concentration of 5 μg/ml, 10μg/ml, or 20μg/ml. After the cells were treated for 24 h, they were pelleted by centrifugation and washed twice with ice-cold PBS. The resultant cell pellets were resuspended in 1 ml of cytosol extraction buffer containing DTT and protease inhibitor and incubated for 15 min on ice. After homogenization, unbroken cells and large debris were removed by centrifugation. The cell lysates were loaded on a 10% gel and subjected to SDS-PAGE followed by Western blotting with anti-RAS, anti-BRAF, anti-ERK, and anti-MITF antibodies (CST, Danvers, MA, USA). Bound antibody was detected with a peroxidase-conjugated anti-rabbit antibody followed by chemiluminescence (ECL System, Waltham, MA, USA) and exposure via autoradiography. The same blots were then probed for β-actin (CST).

*In vivo* reproductive and embryonic toxicity assays
----------------------------------------------------

To explore the reproductive and embryonic toxicity in female mice and their off spring, 24 Non-pregnant ICR female mice were randomly divided into four groups (six per group), comprising two control (pregnant and nongravid) groups and two Cu-NP-treated groups (pregnant and nongravid). Pregnant groups with12 males and 12 females mice were randomly divided into two of four groups, then female and male mice were mated at the ratio of 1:1. After mating, vaginal smear examinations were performed on female animals the following morning. The day on which either sperm or a vaginal plug was detected was regarded as gravidity day 0 (GD0). Pregnant animals were randomly allocated into one of two treatment groups. Mice in the Cu-NPs treatment group were injected with Cu-NPs for14 days,via tail vein at the dosage of 100μg per day per mice, and the control treatment mice were injected with 5% glucose. The pregnants were treated with Cu-NPs begin 7 days before mating continued to GD7. At GD14, the pregnant female sunders went Caesarean section and were then euthanized. Recorded pregnancy outcomes included the numbers of corpora lutea, implantation sites, live fetuses, dead fetuses and resorbed fetuses, as well as fetal gender (Sigma). Blood, ovarian, uterine, and placental samples were also collected. Because the hypothalamic-pituitary-testicular axis is important for reproductive and embryonic development, we tested the serum levels of associated hormones and growth factors, including estrogen, follicle-stimulating hormone (FSH), and progesterone (Sigma). The placenta and ovaries from the control-and Cu-NP-treated groups were all harvested and fixed with 4% paraformaldehyde for at least 24 h. Then, the organs were embedded in paraffin, and hematoxylin and eosin (H&E) staining was performed to observe changes in the organ structure. ICR mice aged 6-8 weeks old and weighing approximately 25-30 g were fed a standard pellet diet supplemented with vitamins and provided water. The mice were housed in cages at the departmental animal facility with a 12h light/dark cycle at a standard temperature. The animals were acclimatized for one week prior to initiation of the experiments and did not show any pathological symptoms.

All the animal experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Bioethics Committee of Second Military Medical University, and all the experiments were performed following relevant guidelines and regulations of Second Military Medical University.

Data and statistical analyses
-----------------------------

The data are presented as the means±S.D. Paired Student\'s t-tests and ANOVA were used to analyze differences in the hormone levels, liver and kidney function indexes, and mitochondrial potential. Significance was established at *P*\<0.05.

Results
=======

Characterization of Cu-NPs
--------------------------

The Cu-NPs were first characterized by TEM. The acquired images showed that the Cu-NPs were all spherical and homogeneous (Figure [1](#F1){ref-type="fig"}A). The diameter of the Cu-NPs in suspension was approximately 100 nm, and the shape and density of the nanoparticles was round and homogeneous, respectively. Further analysis of the diameter (Figure [1](#F1){ref-type="fig"}B) indicated that Cu-NPs had a diameter between approximately 50 and 150 nm.

Figure [1](#F1){ref-type="fig"}C presents the FTIR spectra of the Cu-NPs, showing their composition and quality. The band at 616 cm^-1^ correlates with the stretching vibrations of copper monomer, and there was no significant vibrations of other materials and oxidation state of cooper.

Figure [1](#F1){ref-type="fig"}D of XRD showed the main diffraction pattern and interplanar spacing of the Cu-NPs were similar to those in the standard diffraction pattern of copper monomer. And, some weak peaks of cuprous oxide in the XRD were also tested. Furthermore, no strong characteristic peaks of cooper oxide were detected, suggesting the high purity of the Cu-NPs.

XPS was used to further study the element composition and chemical state of Cu-NPs. Cu2p scan of Cu-NPs showed that the peak was located at 932.5 eV, which is consistent with the cooper in zero and one valance (Figure [1](#F1){ref-type="fig"}E). As we know, the standard peak of cooper in zero and one valance is overlap, which make it difficult to certain the valance of cooper just by the XPS scan. Furthermore, the standard peak of Cu (II) is located between 933.5 eV to 935 eV. In the XPS scan, the peak of C1s was calibrated to 284.8 eV.

Based on the different methods to explore the characterization, the main valence state of Cu-NPs was zero, the cooper (I) may also have little content, and there was no cooper in two valence. So, the Cu-NPs prepared for our experiments were of good quality and purity without any surface modification, and can be used for further biological research.

Cu-NPs inhibit proliferation and induce apoptosis of HTR-8/SVneo cells *in vitro*
---------------------------------------------------------------------------------

After HTR-8/SVneo cells were treated with different concentrations of Cu-NPs, the results showed that the proliferation of HTR-8/SVneo cells was significantly inhibited, and the inhibition ratios of cells at 48h and 72h were nearly 80% and 90%, respectively, at the concentration of 40μg/ml; these differences were statistically significant when compared to the corresponding values in the control group (Figure [2](#F2){ref-type="fig"}B).

To evaluate the apoptotic effect of Cu-NPs on HTR-8/SVneo cells, the cells were exposed to 5, 10, 20, and 40μg/ml Cu-NPs for 48h or 72h. As shown in Figure [2](#F2){ref-type="fig"}A, Cu-NPs induced apoptosis in HTR-8/ SVneo cells in a time-and concentration-dependent manner; furthermore, whereas approximately 20% of cells were apoptotic after exposure to 40μg/ml Cu-NPs for 48h, approximately 60% of cells were apoptotic after exposure to the same concentration for 72 h. In contrast, the control group exhibited 7.97% apoptosis rate.

Cu-NPs induced cell cycle arrest in HTR-8/SVneo cells
-----------------------------------------------------

The early effects of DNA damage can be observed during cell cycle progression. Cells with damaged DNA will accumulate in the G1, S, or G2/M phases. A cell cycle progression analysis was performed and showed that HTR-8/SVneo cells were highly arrested by Cu-NPs in a dose-and time-dependent manner. Approximately 38% of cells exposed to 40 µg/mL Cu-NPs for 48 h were arrested at the G2/M phase, whereas 83% of cells exposed to 40 µg/mL of Cu-NPs for 72h were arrested at the G2/M phase. At the same time, S phase cells became a little higher than the control group at the concentration of 40µg/mL of 48h, however, this phenomenon was observed at the 72h, which indicated that Cu-NPs can induce the G2/M and S phase arrest and the S phase arrest cells were induced apoptosis more easily than the G2/M arrest cells. Additionally, Cu-NP-treated cells exhibited a decrease in the G1 population accompanied by an increase in the G2/M population. The percentage of cells in each phase of the cell cycle was compared to that of controls (Figure [2](#F2){ref-type="fig"}C, D).

Reproductive, embryonic, renal and liver toxicity of Cu-NPs *in vivo*
---------------------------------------------------------------------

To explore the reproductive toxicity of Cu-NPs, we treated pregnant mice with either Cu-NPs at a dosage 100μg per day per mice or with 5% glucose at the same volume. None of the pregnant mice treated with Cu-NPs experienced spontaneous abortion, and no died embryos were present. During our research, we recoded the mice weight of different group, and we found that there was no change in the Cu-NPs treated mice, including both pregnant and unpregnant group (Figure [S1](#SM0){ref-type="supplementary-material"}).

The H&E staining results showed that there was inflammatory cell infiltration as well as congestion and edema in the placentas of Cu-NP-treated pregnant mice (Figure [3](#F3){ref-type="fig"}A).

Measurements of the serum levels of sex hormones and growth factors showed that Cu-NPs can significantly decrease FSH, progesterone, and vascular endothelial growth factor (VEGF) levels in both pregnant and nongravid mice. The estrogen levels in the pregnant group were inhibited by Cu-NPs; however, the difference of nongravid group was not as obvious (Figure [3](#F3){ref-type="fig"}B, C, D).

Furthermore, we tested renal and liver function serum markers to determine renal and liver toxicity, respectively. The renal function markers did not indicate renal toxicity due to Cu-NPs, as there were lower levels of BUN, UA and CR in the Cu-NPs-treated group (Figure [4](#F4){ref-type="fig"}A, B). The serum ALB levels in Cu-NPs-treated pregnant and nongravid mice were slightly lower than those in the corresponding groups treated with vehicle (Figure [4](#F4){ref-type="fig"}C). Other serum liver function markers such as ALP, and GLB in the Cu-NP-treated groups were not lower than those in the untreated groups (Figure [4](#F4){ref-type="fig"}D, E, F). We also performed H&E staining of the kidney, liver, lung, and uterus from Cu-NPs treated mice and observed no significant changes, which suggested that Cu-NPs did not exert obvious renal and liver toxicity at this concentration (Figure [4](#F4){ref-type="fig"}G).

Cu-NPs can block the ERK signaling pathway and decrease the mitochondrial membrane potential
--------------------------------------------------------------------------------------------

As Cu-NPs exhibited significant reproductive toxicity and have been shown to induce the apoptosis of human villous trophoblast cells, it is necessary to explore the mechanism. First, we found that Cu-NPs can significantly inhibit the MMP of human villous trophoblast cells (Figure [5](#F5){ref-type="fig"}A, B), which suggests that Cu-NPs can activate the mitochondria-mediated apoptosis signaling pathway. As ERK signaling is also important for the proliferation of various cell types, we also tested proteins in the ERK signaling pathway. The results showed that Cu-NPs can significantly decrease the expression of BRAF, ERK, and MITF, the latter of which is an important target gene of ERK. However, Cu-NPs did not influence the expression of RAS (Figure [5](#F5){ref-type="fig"}C).

Discussion
==========

Because of their specific properties, copper nanomaterials are widely used in industrial products, consumer products, drug formulations and devices; some examples including solar cells, lithium-ion batteries, lubricant oil polymers/plastics, ink/ceramic gas sensors and electronics. They exist naturally in the environment and can be produced or engineered. In the environment, these particles can be taken up by organisms. Toxicologists and scholars have recognized the potential health risks from nanomaterials, and previous research has demonstrated nano-copper toxicity with in the soil plant system and ecosystem^24,30^. In some studies, copper nanoparticles have been found be toxic to mice at an LD50 of 413 mg/kg via oral gavage; this dose led to pathological changes and injuries to the kidney, liver, and spleen of mice as well as induced hepatic and renal dysfunction^29^. Adamcakova-Dodd A,et al [@B19] founded that prenatal inhalation exposure to copper nanoparticles did not identify histopathology of placentas but caused a profound pulmonary inflammation in dams and strong immunomodulatory effects in offspring. To explore the reproductive toxicity of Cu-NPs without potential confounding factors, followed our preliminary experiments and treatment with 10 mg/kg TiO~2~ NPs via intragastric administration resulted in the most severe organ damage for the mice.in the present study were exposed to Cu-NPs at a dosage 100μg per day per mice(approximately 4mg/kg) via tail vein injection, and we did not observe significant histological changes in the kidney, liver, lung, and uterus from Cu-NP-treated mice compared to those from control-treated mice. The serum levels of renal function markers (BUN, UA and CR) and liver function markers (ALP and GLB) did not show obvious differences between the Cu-NP-treated groups and the control-treated group. These results suggested that Cu-NPs at the concentration administered did not exert obvious renal and liver toxicity (Figure [4](#F4){ref-type="fig"}G). Different administration methods of Cu-NPs have different effects on the liver and kidneys in mice. A previous study [@B31],[@B32] showed that the toxicity of Cu-NPs was probably due to both the nanoparticles themselves and released Cu^2+^. When Cu-NPs enter the gastric lumen, they rapidly react with the hydrogen ions of the gastric juice and convert into their ionic states. Thus, both copper iron overload and metabolic alkalosis contribute to the toxicity of Cu-NPs.

Furthermore, nanoparticles may adversely impact the reproductive system and fertility in mice [@B33],[@B34]. Early studies revealed that titanium dioxide nanoparticles can enter ovarian granulosa cells and inhibit the synthesis of estradiol [@B35]. Triptolide-loaded nanoparticles caused impaired ovarian structure and function, subfertility, and increased follicular apoptosis [@B36],[@B37]. In our experiment, we found inflammatory cell infiltration as well as congestion and edema in the placenta and ovaries of Cu-NPs-treated mice (Figure [3](#F3){ref-type="fig"}A). The number of primordial follicles and corpus lutea was significantly decreased compared to control-treated animals. Cu-NPs exposure to primordial follicles can significantly decrease the FSH, progesterone, estrogen, and VEGF levels in both pregnant and nongravid mice. A shortened early-follicular phase and down-regulation of estrogen and progesterone result in a diminished ovarian reserve [@B38]. Maintenance of the progression of primordial follicles into developing follicles is crucial for ovarian function throughout a woman\'s reproductive life.

Normal placental development is required for embryonic growth, and placental dysfunction has been associated with miscarriage and fetal growth restriction [@B39]. In addition, normal placental development requires the coordinated expression of VEGF and its receptor, soluble fms-like tyrosine kinase-1 (sFLt-1) [@B40]. The placentas of mice treated with nSP70showed variable abnormalities compared to those from control mice. The plasma levels of sFLt-1 in nSP70- and nano-TiO~2~-treated mice were significantly lower than those in control mice [@B14]. Our results were consistent with previous studies, as the data indicated that Cu-NPs can cause pathological change in the placenta. VEGF was also significantly inhibited in both pregnant and nongravid mice.

Our *in vivo* experiments demonstrated that Cu-NPs may adversely impact the reproductive system and fertility of mice. However, there are no reports regarding the toxicity of Cu-NPs on the human reproductive system and fertility. To further investigate the potential reproductive toxicity of Cu-NPs in humans, multiple assays were conducted to analyze whether Cu-NPs can reduce the viability of human extravillous trophoblastic cells.

During early pregnancy, extra villous trophoblasts invade and migrate to affect spiral artery remodeling. Failed or incomplete spiral artery remodeling is associated with various fertility disorders, including miscarriage, intrauterine growth restriction (IUGR) and placental abruption [@B41].

First, to investigate the inhibitory effect of Cu-NPs on proliferation, the CCK-8 assay was used to measure cell viability after nanoparticle treatment. As shown in Figure [2](#F2){ref-type="fig"}B, the proliferation of the trophoblastic cell lines was decreased in a time- and concentration-dependent manner. Based on the CCK-8 results, we performed flow cytometry to determine the apoptotic population among the Cu-NP-treated trophoblastic cell lines. Figure [2](#F2){ref-type="fig"}A shows that Cu-NPs induced apoptosis in HTR-8/ SVneo cells in a time- and concentration-dependent manner. Some research has demonstrated that different nanoparticles can suppress cell viability by different mechanisms. Some types of nanoparticles can induce apoptosis in cells whereas others can activate cell necrosis [@B8],[@B42]. To investigate the mechanism of the cytotoxicity of Cu-NPs, we performed flow cytometry to analyze the effects of Cu-NPs on cell death and the cell cycle. Our investigation revealed that Cu-NPs suppressed the proliferation of HTR-8/SVneo cells and caused cell cycle arrest at G2/M phase as shown in Figure [2](#F2){ref-type="fig"}C.

Mitochondria have key roles during the early stages of apoptosis. Loss of the MMP is a crucial step in triggering apoptosis [@B43]. To determine the effect of Cu-NPs on mitochondrial function as well as their role in inducing cell death, the JC-1 assay was used to analyze the MMP as described earlier. We measured the loss of the MMP in cells treated with Cu-NPs, as shown in Figure [5](#F5){ref-type="fig"}. Ag-NPs and other inorganic nanomaterials can also cause the loss of the MMP and activate the mitochondria-mediated apoptosis signaling pathway [@B44] .

As we know that ERK signaling pathway is sensitive to the cooper concentration and Cu-NPs is made up with cooper element, it is necessary to explore the effects of Cu-NPs on the ERK signaling pathway. Recent studies discovered that activating the ERK pathway can also contribute to inhibited proliferation and the induction of apoptosis [@B45],[@B46]. Cu-NPs are toxic to the skin, and dermal factors and ERK may be key regulators of this cytotoxicity [@B47]. The epidermal growth factor receptor (EGFR) pathway leads to numerous effects such as anti-apoptosis and cell cycle arrest [@B48]. Manna [@B25] found that a moderate concentration of Cu-NPs inhibited activation of the EGFR pathway. Downregulation of the RAS/RAF/MEK/ERK signaling pathway was closely associated with hepatic cell apoptosis and proliferation. The results of our investigation are consistent with previous studies. Other nanomaterials may indirectly cause DNA damage by promoting oxidative stress and inflammatory responses via dysfunction of the mitochondria or inflammasomes [@B12]. In our study, inflammatory cytokines were not investigated owing to current limitations, and future studies may be required.

Conclusions
===========

The results of our study suggest that Cu-NPs induced ovarian and placental pathophysiology and dysfunction in mice. Cu-NPs also induced apoptosis and suppressed proliferation in human HTR-8/SVneo cells in a time- and dose-dependent manner and arrested the cell cycle in a time-dependent manner And, the ERK signaling pathway and mitochondrion disfunction all made great contribution to the toxicity of Cu-NPs. To the best of our knowledge, this is the first report of the cytotoxicity of nanocopper in human extravillous trophoblast cells; furthermore, our study provides information about the safety and care that should be taken before using copper particles in nanomaterials.
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![**Characterization of Cu-NPs. (A)** TEM of Cu-NPs showing that the Cu-NPs were spherical and homogeneous. **(B)** Diameter assessment of Cu-NPs indicating that the diameter of Cu-NPs ranged between approximately 50 and 150 nm. **(C)** FIRT assay. **(D)** XRD patterns assay. (◆: Peak of cooper in zero valence, ☆: Peak of cuprous(I) oxide) **(E)** XPS scan assay.](ijbsv14p1834g001){#F1}

![**Cytotoxicity of Cu-NPs inHTR-8/SVneo cells. (A)** The inhibitory effects of Cu-NPs on proliferation as determined by theCCK8 assay. Cu-NPs can strongly inhibit the proliferation of HTR-8/SVneo cells, and the IC50values after48 h and 72 hof treatment were 20μg/ml and 10μg/ml, respectively. **(B)** Flow cytometry analysis of HTR-8/SVneo cells treated with different concentrations of Cu-NPs for 48 h and 72 h followed by staining with annexin V-FITC and PI. Significant increases in apoptosis were observed in HTR-8/SVneo cells in a dose- and time-dependent manner. The upper-left quadrant in each panel indicates the necrotic population, the upper-right quadrant shows the late apoptotic population, and the lower right quadrant shows the early apoptotic population. **(C)** Cell cycle progression assay of HTR-8/SVneo cells treated with different concentrations of Cu-NPs. Cu-NPs can cause significantly cell cycle arrest at G2/M in a dose-dependent manner, with the most profound results observed at a highest concentration of 40μg/ml. **(D)** Statistics of the cell cycle progression of Cu-NP-treated HTR-8/SVneo cells (Student\'t test, \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.01).](ijbsv14p1834g002){#F2}

![**Reproductive toxicity of Cu-NPs. (A)** H&E-stained images of the placentas and ovaries from Cu-NPs-treated and control-treated mice. More inflammatory cells significantly infiltrated the placentas of Cu-NP-treated mice, and the number of primordial follicles and corpus lutea was significantly decreased. **(B)** Measurement of serum estrogen levels. The serum estrogen levels in the Cu-NPs-treated pregnant mice were lower than those in untreated pregnant mice. There was no statistically significant difference between the treated and untreated nongravid mice (\**P*\<0.05, Student\'s t-test). **(C)** Measurement of serum FSH levels. The serum FSH levels in the Cu-NP-treated mice were lower than those in untreated mice in both the pregnant group and nongravid group (\*\**P*\<0.01, Student\'s t-test). **(D)** Measurement of serum progesterone levels. The serum progesterone levels in the Cu-NP-treated mice were lower than those in untreated mice in both the pregnant group and nongravid group (\*\**P*\<0.01, Student\'s t-test). **(E)** Measurement of serum VEGF levels. The serum VEGF levels in the Cu-NP-treated mice were lower than those in untreated mice in both the pregnant group and nongravid group (\**P*\<0.05, Student\'s t-test).](ijbsv14p1834g003){#F3}

![**Cu-NP renal and liver toxicity. (A)** Measurement of serum BUN levels. The serum BUN levels in the Cu-NP-treated mice were lower than those in the untreated pregnant mice. There was no statistically significant difference between the treated and untreated nongravid mice (\**P*\<0.05, Student\'s t-test). **(B)** Measurement of serum CR levels. The serum CR levels in the Cu-NP-treated mice were lower than those in the untreated pregnant mice. There was no statistically significant difference between the treated and untreated nongravid mice (\**P*\<0.05, Student\'s t-test). **(C)** Measurement of serum ALB levels. The serum ALB levels in the Cu-NP-treated mice were lower than those in the untreated mice in both the pregnant group and nongravid group (\*\**P*\<0.01, \*\*\**P*\<0.001, Student\'s t-test). **(D)** Measurement of serum ALP levels. The serum ALP levels in the Cu-NP-treated mice were higher than those in the untreated pregnant mice. There was no statistically significant difference between treated and untreated nongravid mice (\**P*\<0.05, Student\'s t-test). **(E)** Measurement of serum UA levels. The serum UA levels in the Cu-NP-treated mice were lower than those in the untreated nongravid mice. There was no statistically significant difference between treated and untreated pregnant mice (\**P*\<0.05, Student\'s t-test). **(F)** Measurement of serum GLB levels. The serum GLB levels in the Cu-NP-treated mice were higher than those in the untreated nongravid mice. There was no statistically significant difference between treated and untreated pregnant mice (\**P*\<0.05, Student\'s t-test). **(G)** H&E-stained images of the kidney, liver, lung, and uterus showing that Cu-NPs at a total dose of 4 mg/kg per day did not cause any significant histological changes.](ijbsv14p1834g004){#F4}

![**Measurement of the mitochondrial membrane potential and the expression of proteins in the ERK signaling pathway. (A)** Flow cytometry showed that the mitochondrialmembrane potential of HTR-8/SVneo cells significantly decreased after treatment with Cu-NPs for 48 h and 72 h. **(B)** Fluorescence intensity ratio of JC-1 dimers to JC-1 monomer (\*\*\**P*\<0.01). **(C)** Western blot assay of proteins in the ERK signaling pathway. The BRAF, ERK, and MITF protein expression levels were significantly decreased after Cu-NPs treatment for 48 h. The expression of RAS did not show obvious changes.](ijbsv14p1834g005){#F5}

[^1]: \*Authors contributed equally.

[^2]: Competing Interests: The authors have declared that no competing interest exists.
